Ensign Peak Advisors, Inc Generation Bio Co. Transaction History

Ensign Peak Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.61 - $7.01 $55,594 - $107,954	15,400 Added 101.05%	30,640 $131,000
Q4 2022 Feb 13, 2023	BUY	$3.66 - $6.77 $27,267 - $50,436	7,450 Added 95.64%	15,240 $59,000
Q4 2021 Feb 11, 2022	SELL	$5.99 - $24.97 $3.71 Million - $15.5 Million	-619,973 Reduced 98.76%	7,790 $55,000
Q3 2021 Nov 12, 2021	SELL	$20.0 - $27.43 $2 Million - $2.74 Million	-100,033 Reduced 13.74%	627,763 $15.7 Million
Q2 2021 Aug 13, 2021	BUY	$24.34 - $38.34 $273,094 - $430,174	11,220 Added 1.57%	727,796 $19.6 Million
Q1 2021 May 12, 2021	BUY	$24.74 - $40.2 $10.5 Million - $17 Million	423,759 Added 144.72%	716,576 $20.4 Million
Q4 2020 Feb 12, 2021	BUY	$21.68 - $51.61 $1.6 Million - $3.81 Million	73,848 Added 33.73%	292,817 $8.3 Million
Q3 2020 Nov 12, 2020	BUY	$18.07 - $31.84 $1.59 Million - $2.8 Million	87,969 Added 67.15%	218,969 $6.77 Million
Q2 2020 Aug 12, 2020	BUY	$20.1 - $24.69 $2.63 Million - $3.23 Million	131,000 New	131,000 $2.75 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $79.7M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.